Proposal for a candidate core set of fitness and strength tests for patients with childhood or adult idiopathic inflammatory myopathies [accepted manuscript] by Van Der Stap, Djamilla K. D. et al.
Proposal for a candidate core-set of fitness and strength tests 
for patients with childhood or adult idiopathic inflammatory 
myopathies
Djamilla K.D. van der Stap, MSc1,2, Lisa G. Rider, MD3, Helene Alexanderson, PhD4, Adam 
M. Huber, MD5, Bruno Gualano, PhD6, Patrick Gordon, PhD7, Janjaap van der Net, PhD2, 
Pernille Mathiesen, PhD8, Liam G. Johnson, PhD9,10, Floranne C. Ernste, MD11, Brian M. 
Feldman, MD12,13, Kristin M. Houghton, MD14,15, Davinder Singh-Grewal, PhD16,17,18,19,20, 
Abraham Garcia Kutzbach, MD21,22,23, Li Alemo Munters, PhD24,25, Tim Takken, PhD2, and 
on behalf of the International Myositis Assessment and Clinical Studies Group
1Faculty of Human Movement Sciences, Free University, Amsterdam, The Netherlands 2Child 
Development & Exercise Center, Wilhelmina Children's Hospital, University Medical Center 
Utrecht, Utrecht, The Netherlands 3Environmental Autoimmunity Group, National Institute of 
Environmental Health Sciences, National Institutes of Health, Bethesda, MD 4Department of 
Neurobiology, Care Science and Society, Division of Physical Therapy, Karolinska Institutet and 
the Physical Therapy Clinic, Orthopedic/Rheumatology Unit, Karolinska University Hospital, 
Stockholm, Sweden 5IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada 
6University of Sao Paulo, Sao Paulo, Brazil 7Department of rheumatology, King's College 
Hospital, London, UK 8Paediatric Rheumatology Clinic, Paediatric Department, Rigshospitalet, 
Copenhagen, Denmark 9Institute of Sport, Exercise and Active Living (ISEAL), College of Sport 
and Exercise Science, Victoria University, Melbourne, Australia 10The Florey Institute of 
Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia 11Mayo Clinic in 
Rochester MN, Department of Internal Medicine, Division of Rheumatology 12Departments of 
Pediatrics, Medicine and the Institute of Health Policy, Management & Evaluation, University of 
Toronto, Toronto, Canada 13Division of Rheumatology, The Hospital for Sick Children, Toronto, 
Canada 14British Columbia's Children's Hospital 15The University of British Columbia 16The 
Sydney Children's Hospitals Network Randwick and Westmead Campuses 17The University of 
Sydney, School of Paediatrics and Child Health 18The University of New South Wales, Discipline 
of Child and Maternal Health 19The University of Western Sydney Department of Paediatrics, 
Sydney, Australia 20The John Hunter Children's Hospital, Newcastle Australia 21Director of the 
postgraduate Program of Rheumatology AGAR, School of Medicine University Francisco 
Marroquin, Guatemala 22Professor of Medicine and History of Medicine, School of Medicine 
University Francisco Marroquin, Guatemala 23Member of the executive Committee Hospital 
Herrera Llerandi Guatemala 24Physical Therapy Clinic, Orthopedic/Rheumatology Unit, 
Corresponding author and reprint requests: Tim Takken, MSc, PhD, Child Development & Exercise Center, Wilhelmina 
Children's Hospital, University Medical Center Utrecht, Postal address: KB.02.056.0, P.O. Box 85090, 3508 AB Utrecht, the 
Netherlands. t.takken@umcutrecht.nl, phone: +31 88 75 540 30.. 
Disclosures: None of the authors have any potential conflicts of interest with the content of this manuscript.
HHS Public Access
Author manuscript
J Rheumatol. Author manuscript; available in PMC 2016 July 01.
Published in final edited form as:
J Rheumatol. 2016 January ; 43(1): 169–176. doi:10.3899/jrheum.150270.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Karolinska University Hospital, Stockholm, Sweden. 25Division of Rheumatology and 
Immunology, Department of Medicine, Vanderbilt University, Nashville, USA.
Abstract
OBJECTIVES—Currently there are no evidence-based recommendations regarding which fitness 
and strength tests to use for patients with childhood or adult idiopathic inflammatory myopathies 
(IIM). This hinders clinicians and researchers in choosing the appropriate fitness- or muscle 
strength-related outcome measures for these patients. Through a Delphi survey, we aimed to 
identify a candidate core-set of fitness and strength tests for children and adults with IIM.
METHODS—Fifteen experts participated in a Delphi survey that consisted of five stages to 
achieve a consensus. Using an extensive search of published literature and through the expertise of 
the experts, a candidate core-set based on expert opinion and clinimetric properties was developed. 
Members of the International Myositis Assessment and Clinical Studies Group (IMACS) were 
invited to review this candidate core-set during the final stage, which led to a final candidate core-
set.
RESULTS—A core-set of fitness- and strength-related outcome measures was identified for 
children and adults with IIM. For both children and adults, different tests were identified and 
selected for maximal aerobic fitness, submaximal aerobic fitness, anaerobic fitness, muscle 
strength tests and muscle function tests.
CONCLUSIONS—The core-set of fitness and strength-related outcome measures provided by 
this expert consensus process will assist practitioners and researchers in deciding which tests to 
use in IIM patients. This will improve the uniformity of fitness and strength tests across studies, 
thereby facilitating the comparison of study results and therapeutic exercise program outcomes 
among patients with IIM.
Keywords
exercise; fitness; Myositis; outcome measures; instruments
Introduction
Childhood and adult Idiopathic Inflammatory Myopathies (IIM) are rare systemic 
autoimmune diseases that are characterized by chronic muscle inflammation and weakness 
(1). Patients with the subtypes of IIM – juvenile dermatomyositis (JDM), juvenile 
polymyositis (JPM), adult dermatomyositis (DM), adult polymyositis (PM) and inclusion 
body myositis (IBM) – frequently experience anaerobic and aerobic exercise intolerance and 
fatigue (2-4), and may be limited in their daily physical functioning, which can lead to a 
poorer quality of life (5). This has led to an exploration of interventions such as exercise 
training programs (6). To assess the clinical status of IIM and to quantify changes in 
physical functioning over time, validated fitness and strength tests are essential.
Fitness tests can be divided into three general fitness categories: maximal aerobic fitness 
tests, submaximal aerobic fitness tests and anaerobic fitness tests. Maximal aerobic fitness 
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tests determine the maximal oxygen uptake (VO2max). Submaximal aerobic fitness predict 
aerobic fitness using a submaximal exercise protocol (i.e., an exercise test that does not 
require the participant's maximal effort) (7, 8). Anaerobic fitness tests measure anaerobic 
performance and/or estimate the capacity of anaerobic energy pathways (e.g., 
phosphorylcreatine system and anaerobic glycolysis) during short-duration, high-intensity 
maximal exercise (usually < 30 seconds) (9). Muscle strength tests measure neuromuscular 
performance and can be measured with either static or dynamic muscle contractions. The 
neuromuscular performance measured is specific to the muscle group that is tested, which 
means that, for a comprehensive assessment of muscle strength, several major muscle 
groups must be assessed. A person's maximum strength for a given muscle group is 
corresponding to the maximum force that they can generate. For muscle strength tests, a 
distinction was made between tests that explicitly measure muscle force generation capacity, 
from now on referred to as muscle strength tests, and those that measure performance based 
functional capacity, from now on referred to as muscle function tests.
While fitness and strength testing over time can provide a quantitative assessment of the 
improvement or decline in the physical condition and strength of the patient with IIM, no 
clear recommendations are currently available for clinicians and researchers regarding 
which fitness or strength tests should be used in patients with IIM (1). As a result, a large 
variety of outcome measures have been used to evaluate the fitness and muscle strength of 
patients with IIM; however, most of these instruments have not been validated for this 
patient group (1). With a core-set of fitness- and strength-related outcome measures, the 
uniformity of fitness and strength tests across studies would improve, thereby facilitating the 
comparison of study results, allowing for a better comparison of the effects of therapeutic 
exercise programs.
The aim of this study is to provide a list of evidence-informed fitness- and strength-related 
outcome measures for patients with IIM, and thus facilitate clinicians and researchers to 
make better decisions about which tests to use for this patient group. This core-set of fitness 
and strength tests will serve as a candidate core-set and will be a basis for future research.
Methods
Design
The Delphi survey method was used in this study. The Delphi method has been developed to 
assess opinions and judgments, rather than objective facts, to reach consensus among a 
group of individuals (10). With the use of questionnaires, a panel of informed individuals, 
subsequently called experts, was asked to give feedback about a particular issue to achieve a 
group consensus. Experts were selected based on their activities within the International 
Myositis Assessment and Clinical Studies Group (IMACS) or because of their expertise in 
this research area (see Appendix A for the characteristics of the participants).
During stage 1 of the Delphi survey, literature was searched for fitness- and muscle strength-
related outcome measures that were used in IIM. PubMed and Google Scholar were 
searched up to April 2013 using the following search terms: ‘physical fitness’, ‘exercise 
testing’, ‘exercise’, ‘exercise capacity’, ‘exercise tolerance’, ‘muscle strength’, ‘muscle 
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force’, ‘dermatomyositis’, and ‘myositis’. All articles that were available at the time of the 
search and that matched the inclusion criteria were included in this Delphi survey. Studies 
were included if: 1) the study population of the articles consisted of IIM patients; and 2) the 
studies included an examination of a fitness and/or strength test. No other inclusion and 
exclusion criteria's were applied. Furthermore reference lists of all the selected articles were 
searched for additional studies. The outcome measures were listed and categorized as 
follows: 1) maximal aerobic fitness tests, 2) submaximal aerobic fitness tests, 3) anaerobic 
fitness tests, 4) muscle strength tests and 5) muscle function tests. Afterwards, the experts 
were asked to list additional tests from their clinical practice or from the unpublished or 
published literature, that were not yet listed, in order to make the list as complete as 
possible.
In stage 2, the experts were asked to rate the completed list of fitness and muscle strength 
tests that were identified in the first Delphi stage. All the tests were rated separately for 
children and adults. All experts rated each outcome measure on a 10-point scale for four 
different topics (i.e., safety, suitability, user friendliness, and overall rating). These four 
topics were chosen based on their previous use in a comparable Delphi of fitness outcomes 
for children with cerebral palsy (11). Moreover, the experts were asked for additional 
information about the clinimetric properties of the listed tests. When a test was not studied 
in the IIM population, clinimetric properties were noted as unavailable.
A draft core-set was identified in stage 3 of the Delphi survey. For each category a test, or 
several tests, were selected based on expert ratings (median scores were provided) and 
clinimetric properties of the tests collected during stages 1 and 2. This core-set was 
presented to the experts together with the complete list of outcome measures and their 
ratings. Subsequently, the experts were asked whether they agreed or disagreed with each 
measures inclusion in the suggested core-set.
Based on the comments made by the experts during stage 3, a final draft candidate core-set 
was presented in stage 4. The experts were asked if they agreed or disagreed with the 
suggested core-set for both adults and children. Furthermore a conference call was organized 
to discuss the comments of the experts and to reach consensus among experts.
In stage 5 of the Delphi-survey, the final draft candidate core-set was sent out to all the 
IMACS members through an internet survey to reach consensus. The IMACS members 
could choose to complete the questionnaire anonymously or include their name (see 
Appendix B for the participants who have chosen to include their name). IMACS members 
were asked whether they agreed or disagreed with the tests included in of the core-set, or to 
state if they were unfamiliar with a selected test. Furthermore, they were requested to report 
any important test that in their opinion was missing from the final draft candidate core-set. 
Based on the outcome of the internet survey the final draft candidate core-set was once more 
revised. Consensus was achieved when at least 75% of the IMACS members agreed on the 
inclusion of a given test in the core-set; otherwise, the test was removed from the core-set. 
This pre-defined cut-off score was selected as a comparable cut-off that has been used 
previously by the IMACs (12).
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Statistical Analysis
The experts’ rating of the fitness and strength tests during each of the Delphi stages was 
summarized with descriptive statistics using IBM SPSS Statistics for Windows, version 
20.0.
Results
Fifteen experts participated in this Delphi survey, but only 12 completed the entire survey. 
One expert dropped out during stage 1 due to a lack of time, while the other 2 experts, both 
adult physicians, dropped out during stage 2 as they felt they did not have enough expertise 
to score all tests. The experts’ characteristics can be found in Appendix A.
Results of Delphi stage 1
In the first stage of the Delphi survey, lasting from the 1st of February until 10 June 2013, 22 
tests were identified in the literature search. Furthermore, the experts suggested 16 
additional tests, though 7 of these tests were excluded as they did not measure an outcome of 
interest. See Figure 1 for a flow diagram showing the identification of the tests. For the 
complete list of tests identified, see Appendix C.
For maximal aerobic fitness tests, the incremental cycle ergometer test (intraclass correlation 
coefficient ICC>0.95) was the only test with published reliability data in IIM (12). No data 
on reliability and/or validity of submaximal aerobic fitness tests in IIM were available. For 
anaerobic fitness tests, the Wingate cycle test (ICC>0.85) was the only test with published 
reliability data in IIM (12).
The isometric dynamometer, Manual Muscle Testing (MMT) and the 1 kilogram arm lift 
test were the only muscle strength tests with available reliability and concurrent validity 
data. The isometric dynamometer as used by Stoll et al. (13) showed strong and significant 
intra and interobserver correlations, as well as significant and strong correlations between 
measurements of the left and right side. MMT was highly correlated with total and proximal 
MMT scores and with the Childhood Myositis Assessment Scale (CMAS), and moderately 
correlated with physician global activity, functional disability, magnetic resonance imaging, 
and axial and distal MMT scores, and, in adults, with creatine kinase level (14). The 1 
kilogram arm lift test showed excellent test-retest reliability, and correlated inversely with 
serum creatinine kinase (15).
For several muscle function tests reliability and concurrent validity data were available in 
IIM: the Childhood Myositis Assessment Scale (CMAS) in children (ICC=0,89; highly 
correlated with the Childhood Health Assessment Questionnaire score and with MMT 
scores, and moderately correlated with physician-assessed global disease activity and skin 
activity, parent-assessed global disease severity and muscle magnetic resonance imaging) 
(16); the Functional Index (FI-2) for adults (ICC=0.86-0.99; moderately correlated with the 
shoulder flexion task of the preliminary revised FI and isokinetic measurements of shoulder 
flexion endurance) (14); and the 30-second chair stand test (excellent test-retest reliability; 
correlated inversely with serum creatinine kinase) (15).
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Results of Delphi stage 2
In the second Delphi stage, all experts were asked to rate the complete list of outcome 
measures (Appendix C) for safety, suitability, user friendliness and overall rating for both 
children and adults. The email to the experts was sent out on June 10 and the experts were 
given 7 weeks to complete the survey. The experts had no additional information about the 
clinimetric properties.
Results of Delphi stages 3 and 4
On the 3rd of September 2013 a draft core-set of fitness and strength measures was presented 
to the experts. The tests that made it into the draft core-set were selected because they had 
the highest median scores in their category and/or because they had good reliability and 
validity data. However, because of the lack of available clinimetric properties, most tests 
were included based on expert's opinion, rather than on reliability and validity. The median 
scores and interquartile ranges of the selected tests in the proposed core-set are presented in 
Table 1. Experts got another 7 weeks to respond on the draft core-set.
Based on this draft core-set, a conference call was organized on November 12, 2013 with the 
expert panel, including the three experts who dropped out during previous stages. Using the 
comments from the third Delphi stage and from the conference call, a revised core-set was 
developed (See Table 2). In this revised core-set, two major changes were made; the Åstrand 
cycle test was added in the core-set for the adults, while the CMAS was removed for the 
adults. These changes were discussed during the conference call and consensus about these 
changes and the revised core-set amongst experts was reached.
Results of the final Delphi stage
The online questionnaire was sent out on March 28, 2014, and there were 88 additional 
IMACS members that responded to the online questionnaire, 57 anonymously and 31 
IMACS members that chose to include their name, which was listed in the appendix of 
contributors (Appendix B). Based on the consensus scores (Table 2), some tests were 
removed from the draft candidate core-set as they did not meet the requirement of the ≥ 75% 
consensus agreement. There were no additional tests added, as none of the additional tests 
were mentioned more than twice, which was not enough to reach consensus. A final 
candidate core-set was made, as shown in Table 3. The final candidate core-set includes 5 
tests for children and 6 for adults of which the MMT, CMAS & FI-2 have been validated 
and shown to be reliable in people with IIM.
Discussion
Although several other groups have identified and proposed core-sets of outcome measures 
for the IIM population (17-20), none of these efforts have specifically focused on a core-set 
for fitness- and strength-related outcome.
Maximal aerobic fitness tests
The modified Bruce protocol (2, 21-23) and the incremental cycle ergometer test (24) were 
the two maximal aerobic fitness tests that were included in the core-set for both adults and 
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children after the first four stages of the Delphi survey. Both tests were chosen based on 
expert opinion rather than on their clinimetric properties. There was reliability data available 
for maximal cycle ergometry (25). During the final stage of the Delphi survey there was no 
consensus reached about whether or not to use the modified Bruce Protocol in children. 
Therefore this test was removed from the candidate core-set.
For adult IIM patients, both the modified Bruce protocol and the incremental cycle 
ergometer protocol were included in the final core-set. The experts decided it would be 
better to use the modified Bruce protocol, as it makes the test more accessible for IIM 
patients with reduced physical function. The incremental cycle ergometer test includes 
workload increases dependent on disease activity and body height with 10, 15 or 20 watts/
minute (24, 25). In addition, the expert panel advised to use a 5 watts/minute increase for 
very weak patients.
There was no data available regarding the clinimetric properties of the (modified) Bruce 
protocol or the incremental cycle ergometer test, and therefore further research is needed to 
validate these tests for IIM. Further research is also needed to identify maximal aerobic 
field-tests to include in the core-set.
Submaximal aerobic fitness tests
During the first four Delphi stages, the 6-minute walk test (6-MWT) was included in the 
core-set for both children and adults. As an addition to the core-set for adults, the Åstrand 
cycle test was also included. Both tests were included based on expert opinion rather than on 
clinimetric properties, as these were not available. However, during the final stage of the 
Delphi survey there was clearly no consensus about the use of the Åstrand cycle test in 
adults. Therefore, this test was removed from the final candidate core-set.
The 6-MWT is a practical and simple test that is inexpensive and easy to administer, and it 
allows the individual to set their own pace and voluntarily stop if necessary. The 6-MWT is 
currently one of the core outcome measures in trials involving patients with muscle disease 
(26). All experts agreed that the 6-MWT should be included in the core-set. The Åstrand 
cycle test was initially added as a result of the feedback received in the third Delphi stage 
based on the clinical experience of one of the expert physical therapists. This could be an 
optional test for patients that have difficulty walking. The Åstrand cycle test was added for 
adults only, as it has been found to have large measurement errors in children (27). Even 
though this test is removed from the final candidate core-set, it could still be recommended 
in adult patients that have difficulty walking. Further research is needed to validate these 
tests for IIM.
Anaerobic fitness tests
Only the Wingate cycle test was included in the draft candidate core-set to measure 
anaerobic fitness (28, 29). There were only 2 anaerobic fitness tests identified in the first 
Delphi stage, and the clinimetric properties of the Wingate cycle test in JDM have 
previously been published (29). Therefore, based on expert opinion and clinimetric 
properties, the Wingate cycle test was initially included. However, only 55.6% of the 
IMACS members agreed with this test to be in the core-set for children, and only 61.5% of 
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the IMACS members agreed with this test to be included in the core-set for adults. 
Unfortunately, no other alternative tests of anaerobic fitness have been identified, and 
therefore the final candidate core-set does not include an anaerobic fitness test. There is also 
no field-based anaerobic fitness test available yet for the IIM population. Future studies 
should investigate the clinimetric properties of a field-based anaerobic fitness test, such as 
the muscle power sprint test (9), to determine its potential utility as a fitness test for the IIM 
population.
Muscle strength tests
Based on the first four stages of the Delphi survey, handgrip strength (21-23, 30-34) and 
MMT (31, 34-43) were identified as common measures of muscle strength in both adults 
and children. The IMACS members agreed on these two tests for both children and adults, 
as consensus scores of at least 75% were reached. For a better understanding of patients’ 
muscle strength, isometric, isokinetic or isotonic strength could be measured, depending on 
the available equipment and the patients’ abilities. However, consensus amongst IMACS 
members was not reached on these tests (consensus scores ranged between the 40 to 55%). 
Therefore, these tests were removed from the final candidate core-set (Table 3).
Handgrip strength was included in the final candidate core-set because the consensus scores 
were above the pre-defined 75% cut off. However, as handgrip strength does not always 
capture post-exercise changes in muscle performance, the MMT has been included in the 
core set as an addition to the handgrip strength (1). The panel of experts advised to follow 
the valid and reliable protocol of Rider et al. and test the described 8 muscle groups using 
the Kendall 0-10 scale (44).
Initially, the suggestion of the expert panel was to perform an additional test when a MMT 
score of ≥6 is achieved in a particular muscle group. One could choose to test isometric, 
isokinetic or isotonic strength for that muscle group as well, as they may be a more sensible 
mode of assessment than MMT in patients with little to no severe muscle involvement. For 
isometric and isokinetic strength, this could be done with a dynamometer, and for isotonic 
strength, the panel advised to measure 1 or 10-15 repetition maximum. Some clinimetric 
properties have been found for the 1 kg arm lift test (15), but the experts rated the 1 or 10-15 
repetition maximum higher, and this test was therefore selected instead. The choice between 
isometric, isokinetic or isotonic strength appears to be dependent on the equipment 
available, the abilities of the patient, and the competencies of the clinician.
Even though consensus was not reached on these three additional muscle strength tests, it 
would still be advised to do one of these tests if an additional muscle strength test is needed. 
The low consensus scores of these three additional muscle strength tests could possibly be 
explained by the lack of information the respondents of the Internet survey received. The 
respondents were not aware that these three tests were only listed in addition to the handgrip 
strength and MMT, and were to be considered as an adjunct measure should a clinician need 
more insight in the patient's strength. Another explanation for these low consensus scores 
may be the limited availability of testing equipment in the centers.
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There were no clinimetric properties available for the selected handgrip, isokinetic and 
isotonic strength tests. Further research is needed to determine whether these muscle 
strength tests and corresponding assessment equipment are valid and reliable to use in 
patients with IIM.
Muscle function test
For muscle function, it is advised to perform the CMAS in children and the FI-2 in adults as 
both tests have been found to be valid and reliable in patients with IIM. Clinimetric 
properties have been demonstrated in the 30 seconds chair stand test (15), but this test was 
not included in the core-set as it was found to be redundant after the inclusion of the CMAS 
and/or FI-2. Consensus scores of both the CMAS in children and the FI-2 in adults were 
high (both 95%).
Limitations
One of the limitations of this Delphi was the fact that the IMACS members that participated 
in the final Delphi round do not have extensive experience with exercise physiologic studies 
and exercise tests. This could have resulted in a final list of tests biased towards what tests 
the panelists are familiar with, and not what might be the most appropriate tests for patients 
with IIM.
Recommendations for future research and clinical practice
Future clinical trials studying the effects of rehabilitation or exercise for patients with IIM 
are advised to incorporate the outcome measures listed in this core-set, since this will 
facilitate the comparability between studies. A recent review on the efficacy of exercise 
training in patients with IIM reported that a large variety of outcome measures were used in 
the studies included, impeding data pooling and meta-analysis (6).
Further, the current report identified a major gap in the knowledge regarding the clinimetric 
properties of many outcome measures in juvenile and adult IIM patients. In the final 
candidate core-set presented in this article MMT, CMAS and FI-2 are the only tests with 
good reliability and validity data. Therefore, more research in this area is warranted.
Availability of the tests in centers and the expertise needed to carry out these tests were not 
identified in this Delphi as leading arguments to have a test included in the core-set. 
However, for implementation in clinical practice and research we advise researchers and 
clinicians to obtain experience in carrying out these tests before use.
Conclusion
We have presented a candidate core-set of fitness and strength tests for patients with 
childhood and adult idiopathic inflammatory myopathies. The core-set will help standardize 
the conduct and reporting of clinical trials of exercise therapies, and assist practitioners in 
deciding which tests to use when assessing patients with IIM in the clinical setting. This will 
facilitate comparability of results across studies and clinical programs.
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Appendix B: Characteristics of the participants
Fifteen experts participated in this Delphi survey including adult physicians (n=5), 
pediatricians (n=4), physical therapists (n=4), and exercise physiologists (n=2). 
Furthermore, five experts were specialized in adult rheumatology and seven experts in 
pediatric rheumatology. All experts worked with one or more subtypes of IIM: JDM (n=11), 
JPM (n=7), DM (n=7), PM (n=7) and IBM (n=7). The median (interquartile range) 
experience with IIM patients was 15 years (7-25), with a median annual number of IIM 
patients treated of 50 (20-87). The experts were an international group, originating from the 
Netherlands (n=1), the USA (n=2), Canada (n=3), the UK (n=2), Brazil (n=1), Guatemala 
(n=1), Sweden (n=2), Denmark (n=1), and Australia (n=2). Most experts were members of 
IMACS, and participated also in the Rehabilitation and Exercise Special Interest Group, or 
have a high expertise in this research area.
Appendix C: Overview of tests that were identified during the first Delphi 
stage
Appendix C
Overview of tests that were identified during the first Delphi stage
Tests Children Adults
Maximal aerobic fitness test
    (Modified) Bruce protocol + +
    Balke protocola + +
    Treadmill test + +
    Cycle test + +
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Tests Children Adults
Submaximal aerobic fitness test
    Treadmill testa + +
    Åstrand 6 minute cycle testa + +
    6-MWT + +
    RFWTa + +
    CT12a + +
Anaerobic fitness test
    30-s Wingate cycle test + +
    Isokinetic Wingate cycle testa + +
Muscle strength test
    Handgrip strength
        Hand-grip dynamometer + +
    Isometric strength
        Isometric dynamometer + +
        Sphygmomanometrya + +
        MVICT + +
        Modus M393 dynamometer + +
    Isokinetic strength
        Isokinetic dynamometer + +
    Isotonic strength
        Dynamic dynamometer + +
        Variable resistance exercise + +
        1/10-15 RM + +
        1kg arm lift test + +
    MMT + +
Muscle function test
    CMAS + +
    Functional Index + +
    Subscale 8 BOT-2 + +
    TUG + +
    30s chair stand test + +
    MEFT + +
    Squats in 30 seca + +
    Sit-ups in 30 seca + +
Other test
    Houston non-exercise testa + +
a
Test was added by the experts during the first stage. 6-MWT: 6-minute walk test; RFWT: Rockport Fitness Walking Test; 
CT12: Coopers 12 minute walk/run test; RM: repetition maximum; VRM: voluntary repetition maximum; BOT-2: 
Bruininks-Osteretsky Test, second edition; MMT: Manual Muscle Testing; CMAS: Childhood Myositis Assessment Scale; 
TUG: Timed Up and Go test; MVICT: maximum voluntary isometric contraction testing; MEFT: muscle endurance with 
functional test.
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Appendix D. Short description of test in final candidate core-set
Bruce Protocol
The Bruce protocol is an treadmill exercise stress test with stages of 3 minutes. The 
treadmill is started with 2.74 km/hr (1.7 mph) and a gradient of 10% and then increases 
every 3 minutes in speed and gradient as shown in the table below.
Stage Speed (km/hr) Speed (mph) Gradient
1 2.74 1.7 10
2 4.02 2.5 12
3 5.47 3.4 14
4 6.76 4.2 16
5 8.05 5.0 18
6 8.85 5.5 20
7 9.65 6.0 22
8 10.46 6.5 24
9 11.26 7.0 26
10 12.07 7.5 28
Reference: Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic 
assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973; 
85(4):546-562.
Incremental cycle ergometer test
This maximal exercise test uses an electronically braked cycle ergometer. The seat height is 
adjusted to the participants leg length. After 1 minute of unloaded cycling, the workload 
increases by 10, 15, or 20 watts every minute depending on actual disease activity and body 
height. Participants maintain a pedal cadence of 60-80 revolutions per minute via feedback 
from a visual display on the ergometer. This protocol continues until the participant stops 
due to volitional exhaustion, despite strong verbal encouragements from the investigators.
Reference: Takken T, van der Net J, Helders PJ. Anaerobic exercise capacity in patients 
with juvenile-onset idiopathic inflammatory myopathies. Arthritis Rheum 2005;53:173-7.
6 minute walk test (6MWT)
The 6 minute walk test (6MWT) measures the distance an individual is able to walk over a 
total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as 
possible in six minutes. The individual is allowed to self-pace and rest as needed as they 
traverse back and forth along a marked walkway.
Holland AE, Spruit MA2, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, 
Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill 
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SM, Hernandes NA2, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh 
SJ. An official European Respiratory Society/American Thoracic Society technical standard: 
field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44(6):1428-46.
Handgrip strength
The subject holds the dynamometer in the hand to be tested, with the arm at right angles and 
the elbow by the side of the body. The handle of the dynamometer is adjusted if required - 
the base should rest on first metacarpal (heel of palm), while the handle should rest on 
middle of four fingers. When ready the subject squeezes the dynamometer with maximum 
isometric effort, which is maintained for about 5 seconds. No other body movement is 
allowed. The subject should be strongly encouraged to give a maximum effort.
Reference: Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. (1985). 
Grip and pinch strength: normative data for adults. Archives of Physical Medicine and 
Rehabilitation 66: 69–74.
Manual Muscle Testing (MMT) with the Medical Research Council 0-10 scale
Different muscle groups are evaluated following the MRC 0-10 scale:
Scale Description
0 No contraction of muscle is felt
T Tendon is visible, but no movement is detectable
1 Moves trough partial range of motion in the horizontal plane
2 Moves trough completion of range of motion in the horizontal plane
3 -Moves trough completion of range of motion against resistance in the horizontal plane
-Holds against pressure or moves through partial range of motion in an antigravity position
4 Gradual release from test position in an antigravity position
5 Holds test position (no added pressure) in an antigravity position
6 Holds test position against slight pressure in an antigravity position
7 Holds test position against slight to moderate pressure in an antigravity position
8 Holds test position against moderate pressure in an antigravity position
9 Holds test position against moderate to strong pressure in an antigravity position
10 Holds test position against strong pressure in an antigravity position
Reference: Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, et 
al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile 
idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 2010;62:465-72.
The Childhood Myositis Assesment Scale (CMAS)
The Childhood Myositis Assessment Scale (CMAS) was developed to assess muscle 
function in the areas of strength and endurance across a wide range of abilities and age 
groups in children with juvenile dermatomyositis (JDM) and polymyositis. There are 14 
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ordinal items included which were chosen to assess primarily axial and proximal muscle 
groups and are ranked with standard performance and scoring methods. The CMAS has a 
potential range of 0-52 with higher scores indicating greater muscle strength and endurance.
Reference: Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini 
EH, Hicks JE, Levinson JE, Mier R, Pachman LM, Passo MH, Perez MD, Reed AM, 
Schikler KN, Smith M, Zemel LS, Rider LG. Development of validated disease activity and 
damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood 
Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle 
function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. 
Arthritis Rheum. 1999 Oct;42(10):2213-9.
Functional index (FI)
The FI-2 is a functional outcome developed for patients with adult polymyositis or 
dermatomyositis assessing muscle endurance in seven muscle groups. Each muscle group is 
scored as the number of correctly performed repetitions with 60 or 120 maximal number of 
repetitions depending on muscle group. The FI-2 is a further development of the original 
Functional Index (FI) and has been validated as to content and construct validity and intra- 
and inter-rater reliability.
Reference: Alexanderson H, Broman L, Tollbäck A, Lundberg IE, Stenström CH. 
Functional Index-2: validity and reliability of a disease-specific measure of impairment in 
patients with polymyositis and dermatomyositis. Arthritis Rheum (Arthritis Care Res), 
2006;55:114-22.[
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Figure 1. 
Flow diagram on the identification of the tests.
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Table 1
Overview of tests that were presented during stage 3 of the Delphi survey
Tests Safety median score 
[25-75% IQR]
Suitability median 
score [25-75% IQR]
User friendliness 
median score [25-75% 
IQR]
Overall rating median 
score [25-75% IQR]
Maximal aerobic fitness test
(Modified) Bruce protocol
Children: 8.0 [7.00-10] 8.0 [7.00-10] 7.0 [5.00-8.00] 7.0 [7.00-9.00]
Adults: 8.5 [7.00-10] 9.0 [7.25-10] 7.5 [6.25-9.50] 7.0 [6.50-9.50]
Cycle test
Children: 8.5 [7.00-9.75] 8.0 [5.00-9.00] 7.5 [6.25-8.00] 8.0 [6.00-8.75]
Adults: 9.0 [8.25-9.75] 8.5 [8.00-9.75] 7.5 [6.25-8.00] 8.0 [7.25-8.75]
Submaximal aerobic fitness test
6-MWT
Children: 10 [9.00-10] 8.0 [7.00-10] 9.0 [8.00-10] 9.0 [7.00-10]
Adults: 10 [9.00-10] 8.0 [5.00-8.00] 9.0 [8.00-10] 8.0 [6.75-9.25]
Anaerobic fitness test
Wingate cycle test
Children: 8.0 [8.00-8.00] 8.0 [5.00-9.00] 8.0 [5.00-8.00] 8.0 [6.00-8.00]
Adults: 8.0 9.0 6.0 7.0 [6.25-8.50]
Muscle strength test
Handgrip strength
Handgrip dynamometer
Children: 10 [10-10] 6.0 [5.00-8.00] 6.0 [6.00-7.00] 6.0 [5.50-7.00]
Adults: 10 [10-10] 8.0 [6.00-8.00] 6.0 [6.00-7.00] 7.0 [5.00-8.25]
MMT
Children: 10 [9.00-10] 8.0 [7.00-10] 9.0 [8.00-10] 8.0 [7.00-10]
Adults: 10 [9.00-10] 8.0 [7.00-10] 8.0 [7.50-10] 8.0 [7.00-8.00]
Isometric strength
Isometric dynamometer
Children: 9.0 [9.00-10] 8.0 [7.00-9.00] 8.0 [6.00-9.00] 8.0 [7.00-9.00]
Adults: 9.5 [9.00-10] 8.0 [6.25-9.00] 7.5 [6.00-8.00] 7.5 [5.50-8.75]
Isokinetic strength
Isokinetic dynamometer
Children: 9.0 [9.00-10] 7.0 [2.00-8.00] 5.0 [2.00-6.00] 6.0 [2.00-7.00]
Adults: 10 [9.00-10] 8.0 [7.00-9.00] 5.0 [4.00-6.00] 7.0 [6.00-8.00]
Isotonic strength
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Tests Safety median score 
[25-75% IQR]
Suitability median 
score [25-75% IQR]
User friendliness 
median score [25-75% 
IQR]
Overall rating median 
score [25-75% IQR]
1/10-15 RM
Children: 8.0 [6.00-10] 8.0 [7.00-9.25] 7.0 [6.00-8.00] 7.5 [6.75-8.00]
Adults: 7.5 [5.25-10] 7.0 [6.25-9.75] 8.0 [6.25-9.75] 7.0 [6.00-8.00]
Muscle function test
CMAS
Children: 10 [9.00-10] 9.0 [8.00-10] 10 [9.00-10] 9.0 [9.00-10]
Adults: 10 [9.50-10] 8.0 [0.50-9.00] 10 [5.00-10] 8.0 [3.50-9.00]
Functional Index
Adults: 9.5 [8.75-10] 8.0 [6.50-8.00] 7.5 [7.00-9.25] 7.5 [7.00-8.25]
Legend: All tests were rated on a 10-point scale. IQR: interquartile range; 6-MWT: 6-minute walk test; MMT: Manual Muscle Testing; RM: 
Repetition Maximum; CMAS: Childhood Myositis Assessment Scale.
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Table 2
Results of the online questionnaire among all IMACS members during Stage 5 of the Delphi survey
Tests Children Consensus agreement in % (N) Adults Consensus agreement in % (N)
Maximal aerobic fitness test
    (Treadmill) Modified Bruce protocol 58.3 % (12) 87.5 % (16)
    (Cycle ergometer) Incremental exercise test 75.0 % (14) 83.3 % (18)
Submaximal aerobic fitness test
    6-MWT 85.7 % (21) 89.3 % (28)
    Astrand cycle testa NA 20.0 % (15)
Anaerobic fitness test
    Wingate cycle test 55.6 % (9) 61.5 % (13)
Muscle strength test
    Handgrip strength
        Handgrip dynamometer 82.4 % (17) 81.5 % (27)
    MMT 95.0 % (20) 96.6 % (29)
    Isometric strength
        Isometric dynamometer 46.2 % (13) 54.5 % (22)
    Isokinetic strength
        Isokinetic dynamometer 41.7 % (12) 45.5 % (22)
    Isotonic strength
        1/10-15 RM 53.8 % (13) 54.5 % (22)
Muscle function test
    CMAS 95.0 % (20) NA
    Functional Index NA 95.0 % (20)
Legend:
a
Test was added by the experts during the first stage. The % provided in this table reflects the percentage of the IMACS members that agree on the 
given test of the core-set. 6-MWT: 6-minute walk test; MMT: Manual Muscle Testing; RM: Repetition Maximum; CMAS: Childhood Myositis 
Assessment Scale; NA: not applicable.
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Table 3
Final candidate core-set of fitness and muscle strength tests
Tests Children Adults
Maximal aerobic fitness test
    (Treadmill) Modified Bruce protocol - +
    (Cycle ergometer) Incremental exercise test + +
Submaximal aerobic fitness test
    6-MWT + +
Muscle strength test
    Handgrip strength
        Handgrip dynamometer + +
    MMT + +
Muscle function test
    CMAS + -
    Functional Index-2 - +
Legend: 6-MWT: 6-minute walk test; MMT: Manual Muscle Testing; CMAS: Childhood Myositis Assessment Scale.
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